Interesting set of results.
The immune cell infiltrates are reduced in PPS treated mice by around 20%, which is ideal since this will allow the immune system to continue fighting the virus infection while simultaneously reducing the damage caused by the immune response. The reduction in immune cell infiltrates appears to be linked to the reduced collagen deposition observed in the lungs of mice given PPS.
I'm not convinced by the fibrosis story the PAR management team are trying to sell here, but what is clear is PPS has a noticable impact on the inflammatory response - there are several indicators that support PPS reduces the acute inflammatory response, including biomarker data.
The fact that very little weight loss was observed for the mice given PPS indicates that they only experienced mild symptoms associated with influenza A infection, while those that received saline experienced more severe symptoms.
- Forums
- ASX - By Stock
- PAR
- Ann: POSITIVE TOP-LINE RESULTS FROM PRECLINICAL STUDY IN ARDS
Ann: POSITIVE TOP-LINE RESULTS FROM PRECLINICAL STUDY IN ARDS, page-28
-
- There are more pages in this discussion • 53 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
19.0¢ |
Change
-0.010(5.00%) |
Mkt cap ! $66.54M |
Open | High | Low | Value | Volume |
20.0¢ | 21.0¢ | 19.0¢ | $203.4K | 1.019M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 387930 | 19.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.5¢ | 65468 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
14 | 387930 | 0.190 |
3 | 57000 | 0.185 |
10 | 205428 | 0.180 |
6 | 140904 | 0.175 |
8 | 615605 | 0.170 |
Price($) | Vol. | No. |
---|---|---|
0.205 | 65468 | 2 |
0.210 | 28079 | 4 |
0.215 | 30000 | 1 |
0.220 | 27066 | 4 |
0.225 | 21604 | 2 |
Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |